94 related articles for article (PubMed ID: 7805759)
1. Thermodynamics of the binding of BTCP (GK 13) and related derivatives on the dopamine neuronal carrier.
Billaud G; Menard JF; Marcellin N; Kamenka JM; Costentin J; Bonnet JJ
Eur J Pharmacol; 1994 Aug; 268(3):357-63. PubMed ID: 7805759
[TBL] [Abstract][Full Text] [Related]
2. Studies of the biogenic amine transporters. III. Demonstration of two binding sites for [3H]GBR12935 and [3H]BTCP in rat caudate membranes.
Akunne HC; Dersch CM; Cadet JL; Baumann MH; Char GU; Partilla JS; de Costa BR; Rice KC; Carroll FI; Rothman RB
J Pharmacol Exp Ther; 1994 Mar; 268(3):1462-75. PubMed ID: 7908058
[TBL] [Abstract][Full Text] [Related]
3. Interaction of two sulfhydryl reagents with a cation recognition site on the neuronal dopamine carrier evidences small differences between [3H]GBR 12783 and [3H]cocaine binding sites.
Refahi-Lyamani F; Saadouni S; Costentin J; Bonnet JJ
Naunyn Schmiedebergs Arch Pharmacol; 1995 Feb; 351(2):136-45. PubMed ID: 7770096
[TBL] [Abstract][Full Text] [Related]
4. Complex ionic control of [3H]GBR 12783 binding to the dopamine neuronal carrier.
Héron C; Billaud G; Costentin J; Bonnet JJ
Eur J Pharmacol; 1996 Apr; 301(1-3):195-202. PubMed ID: 8773464
[TBL] [Abstract][Full Text] [Related]
5. Thermodynamic analyses of the binding of substrates and uptake inhibitors on the neuronal carrier of dopamine labeled with [3H]GBR 12783 or [3H]mazindol.
Bonnet JJ; Benmansour S; Costentin J; Parker EM; Cubeddu LX
J Pharmacol Exp Ther; 1990 Jun; 253(3):1206-14. PubMed ID: 2141637
[TBL] [Abstract][Full Text] [Related]
6. Specific binding of [3H]GBR 12783 to the dopamine neuronal carrier included in polarized membranes.
Billaud G; Costentin J; Bonnet JJ
Eur J Pharmacol; 1993 Nov; 247(3):333-40. PubMed ID: 8307105
[TBL] [Abstract][Full Text] [Related]
7. Translocation of dopamine and binding of 2 beta-carbomethoxy-3 beta-(4-fluorophenyl) tropane (WIN 35,428) measured under identical conditions in rat striatal synaptosomal preparations. Inhibition by various blockers.
Xu C; Coffey LL; Reith ME
Biochem Pharmacol; 1995 Jan; 49(3):339-50. PubMed ID: 7857321
[TBL] [Abstract][Full Text] [Related]
8. Evidence for the sequential formation of two complexes between an uptake inhibitor, GBR 12783 [1-[2-(diphenylmethoxy)ethyl]-4-(3-phenyl-2-propenyl)piperazine], and the neuronal transporter of dopamine.
Do-Régo JC; Hue H; Costentin J; Bonnet JJ
J Neurochem; 1999 Jan; 72(1):396-404. PubMed ID: 9886093
[TBL] [Abstract][Full Text] [Related]
9. Cocaine and GBR 12783 recognize nonidentical, overlapping binding domains on the dopamine neuronal carrier.
Saadouni S; Refahi-Lyamani F; Costentin J; Bonnet JJ
Eur J Pharmacol; 1994 Jul; 268(2):187-97. PubMed ID: 7957640
[TBL] [Abstract][Full Text] [Related]
10. Photoaffinity labeling of the dopamine reuptake carrier protein with 3-azido[3H]GBR-12935.
Berger SP; Martenson RE; Laing P; Thurkauf A; Decosta B; Rice KC; Paul SM
Mol Pharmacol; 1991 Apr; 39(4):429-35. PubMed ID: 2017146
[TBL] [Abstract][Full Text] [Related]
11. Further studies of the structure-activity relationships of 1-[1-(2-benzo[b]thienyl)cyclohexyl]piperidine. Synthesis and evaluation of 1-(2-benzo[b]thienyl)-N,N-dialkylcyclohexylamines at dopamine uptake and phencyclidine binding sites.
He X; Raymon LP; Mattson MV; Eldefrawi ME; de Costa BR
J Med Chem; 1993 Dec; 36(25):4075-81. PubMed ID: 8258830
[TBL] [Abstract][Full Text] [Related]
12. Effect of CH3HgCl and several transition metals on the dopamine neuronal carrier; peculiar behaviour of Zn2+.
Bonnet JJ; Benmansour S; Amejdki-Chab N; Costentin J
Eur J Pharmacol; 1994 Jan; 266(1):87-97. PubMed ID: 8137886
[TBL] [Abstract][Full Text] [Related]
13. 1-[1-2-Benzo[b]thiopheneyl)cyclohexyl]piperidine hydrochloride (BTCP) yields two active primary metabolites in vitro: synthesis, identification from rat liver microsome extracts, and affinity for the neuronal dopamine transporter.
Deleuze-Masquefa C; Michaud M; Vignon J; Kamenka JM
J Med Chem; 1997 Dec; 40(25):4019-25. PubMed ID: 9406593
[TBL] [Abstract][Full Text] [Related]
14. Modulation by dopamine of [3H]N-[1-(2-benzo(b)thiophenyl)cyclohexyl]piperidine ([3H]BTCP, a phencyclidine derivative) binding to the dopamine uptake complex.
Maurice T; Barbanel G; Kamenka JM; Vignon J
Neuropharmacology; 1991 Jun; 30(6):591-8. PubMed ID: 1681444
[TBL] [Abstract][Full Text] [Related]
15. Localization of the dopamine uptake complex using [3H]N-[1-(2-benzo(b)thiophenyl)cyclohexyl]piperidine ([3H]BTCP) in rat brain.
Filloux F; Hunt MA; Wamsley JK
Neurosci Lett; 1989 May; 100(1-3):105-10. PubMed ID: 2527343
[TBL] [Abstract][Full Text] [Related]
16. Endogenous dopamine differently affects N-[1-(2-benzo(b)thiophenyl)cyclohexyl]piperidine and cocaine binding to the dopamine uptake complex.
Maurice T; Barbanel G; Vignon J
Gen Pharmacol; 1993 Jan; 24(1):191-4. PubMed ID: 8482495
[TBL] [Abstract][Full Text] [Related]
17. Evidence for mutually exclusive binding of cocaine, BTCP, GBR 12935, and dopamine to the dopamine transporter.
Reith ME; de Costa B; Rice KC; Jacobson AE
Eur J Pharmacol; 1992 Dec; 227(4):417-25. PubMed ID: 1446712
[TBL] [Abstract][Full Text] [Related]
18. The low affinity PCP sites in the rat cerebellum not only bind TCP-like but also BTCP-like structures.
Espaze F; Hamon J; Hirbec H; Vignon J; Kamenka JM
Eur J Med Chem; 2000 Mar; 35(3):323-31. PubMed ID: 10785558
[TBL] [Abstract][Full Text] [Related]
19. In vivo labelling of the mouse dopamine uptake complex with the phencyclidine derivative [3H]BTCP.
Maurice T; Vignon J; Kamenka JM; Chicheportiche R
Neurosci Lett; 1989 Jun; 101(2):234-8. PubMed ID: 2771169
[TBL] [Abstract][Full Text] [Related]
20. Synthesis and biological evaluation of 1-[1-(2-benzo[b]thienyl)cyclohexyl]piperidine homologues at dopamine-uptake and phencyclidine- and sigma-binding sites.
He XS; Raymon LP; Mattson MV; Eldefrawi ME; de Costa BR
J Med Chem; 1993 Apr; 36(9):1188-93. PubMed ID: 8098066
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
